Radial wall strain for residual risk stratification after percutaneous coronary intervention.

EuroInterventionSep 21, 2026 (epub)
Clinical ResearchCardiology

Jiayue Huang, Shengxian Tu, Haocheng Huang et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial investigated the prognostic value of radial wall strain (RWS) in predicting cardiac events in non-target vessels after percutaneous coronary intervention. Analyzing data from 1,551 patients, the study found that a baseline RWS max ≥13% independently predicted a non-target vessel-oriented composite endpoint (NT-VOCE) with an adjusted hazard ratio of 4.82 (95% CI: 3.14-7.40; p<0.0001).

Key findings

  • Baseline RWS max ≥13% predicted NT-VOCE with an adjusted HR of 4.82 (95% CI: 3.14-7.40; p<0.0001).
  • The adjusted area under the curve for RWS was 0.73 (95% CI: 0.69-0.78; p<0.0001).
  • In high-quality angiographic images, RWS showed an adjusted HR of 6.89 (95% CI: 3.15-15.07; p<0.0001) for NT-VOCE.

Why it matters

Understanding the prognostic value of RWS can help clinicians identify patients at higher risk for adverse cardiovascular events, potentially guiding more tailored follow-up and intervention strategies.

Source

Published in EuroIntervention. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.